Androgen Receptor Current Events | Androgen Receptor News | 3
|
| Page
3 of
28 |
546 Results |
|
|
|
Sort By:
Page Views | Date |
Prostate cancer screening creates new dilemma for men, says professor
Between 70 and 80 per cent of prostate cancer was now being diagnosed at a stage where it may be curable, a press conference at ECCO 11 - The European Cancer Conference in Lisbon heard today (Wednesday, October 23, 2001). "We used to have a situation in which one of every two patients diagnosed with the disease would die. Today only three to... view more... (2001-10-23)
A Novel Strategy for Combating Aids-Related Fungal Infections
Research at the Sir William Dunn School of Pathology has identified Dectin-1 as the beta-glucan receptor on immune cells. This finding may be of use in the prophylactic prevention of a variety of infections, especially in surgical patients, and in the treatment of cancer. The identification of Dectin-1 as the beta-glucan receptor may also provide... view more... (2004-10-08)
Androgen therapy may slow progress of Alzheimer's disease
Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression. view more (2006-12-20)
Standard treatment for prostate cancer may encourage spread of disease
A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests. view more (2007-10-01)
Scientists discover way to block growth of prostate cancer cells
Scientists have discovered for the first time a specific biochemical pathway by which the sex hormone, androgen, increases levels of harmful chemicals called reactive oxygen species (ROS) in the prostate gland that play a role in the development of prostate cancer. view more (2006-11-08)
Prostate cancer therapy may increase risk of death from heart disease in older men
Androgen deprivation therapy-one of the most common treatments for prostate cancer-may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions. view more (2007-02-26)
Stoned sea-squirts
The psychoactive ingredient of the drug cannabis exerts its effects on the human brain by activating proteins known as cannabinoid receptors. Dr. Maurice Elphick of Queen Mary, University of London has uncovered the first evidence that cannabinoid receptors may not be unique to humans and other vertebrates. The genome of the sea- squirt was... view more... (2004-03-31)
Chemical genomic screening identifies novel therapeutic strategies for cancer
A sophisticated new chemical genetic screening strategy that serves as a tool for identifying anticancer compounds may significantly enhance the drug discovery process. view more (2006-09-29)
Hormone therapy before radiation seed implants for prostate cancer
Men over 70 years of age with early-stage prostate cancer have 20 percent higher mortality if they are treated first with hormone therapy before being treated with radiation seed implants (brachytherapy), compared to men who are treated with brachytherapy alone. view more (2008-09-23)
Researchers identify taste receptor responsible for caffeine detection
By studying how taste-receptor mutations impact fruit fly behavior, researchers have identified a taste receptor responsible for the detection of caffeine, a bitter compound known to activate certain taste-receptor neurons, as well as impact various aspects of physiology. view more (2006-09-19)
Study reveals inaccuracies in studies of cancer treatment
Certain biases may exist in observational studies that compare outcomes of different cancer therapies, making the results questionable. view more (2008-04-21)
Breathe deep: Which patients could benefit from inhaled steroids in cystic fibrosis?
A specific variation in the glucocorticoid receptor gene is associated with lung disease progression in cystic fibrosis, research published this week in the online open access journal Respiratory Research reveals. view more (2007-11-29)
Help for bleeding hearts: new research links a third protein to blood-clotting disorders
Studying receptors on the surface of blood platelets, sticky cells that cause blood to clot, has given one Rockefeller researcher new insight into potential causes and treatments for certain cardiovascular diseases. view more (2006-04-20)
Variant of vitamin D receptor gene linked to melanoma risk
A new analysis indicates an association between a gene involved in vitamin D metabolism and skin cancer. Published in the November 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that individuals with certain variants in a vitamin D-related gene, called BsmI, may be at an increased risk of... view more... (2008-09-22)
Prostate cancer immunotherapy significantly prolongs survival in men with advanced prostate cancer
Sipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be presented April 28 at the American Urological Association (AUA) Annual Scientific Meeting in Chicago. view more (2009-04-29)
New discovery may help doctors treat infertility
New research suggests that medications commonly referred to as fertility drugs may be ineffective for women who lack a gene called the estrogen receptor beta. view more (2005-07-21)
Common herbicides and fibrates block nutrient-sensing receptor found in gut and pancreas
According to new research from the Monell Center and the Mount Sinai School of Medicine, certain common herbicides and lipid-lowering fibrate drugs act in humans to block T1R3, a nutrient-sensing taste receptor also present in intestine and pancreas. view more (2009-10-12)
OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer
Oregon Health & Science University Cancer Institute researchers, in a first-of-its-kind study, have found that even men with advanced prostate cancer can take a much-needed safe break, or holiday, from chemotherapy. view more (2008-02-26)
Contraception: progress brings hope for new methods for men
For decades, pundits have predicted new contraceptives for men within the next 5 to 10 years. Are we really getting any closer? Judging from work presented today at the second "Future of Male Contraception" conference, the answer may finally be yes. view more (2007-09-28)
Matrix fragments trigger fatal excitement
Shredded extracellular matrix (ECM) is toxic to neurons. Chen et al. reveal a new mechanism for how ECM demolition causes brain damage. The study will appear in the December 29, 2008 issue of The Journal of Cell Biology (www.jcb.org). view more (2008-12-30)
|
|
| Page
3 of
28 |
546 Results |
|
|
|
Sort By:
Page Views | Date |
|
